CANDIN® (Candida albicans Skin Test Antigen For Cellular Hypersensitivity)
The only FDA-approved delayed-type hypersensitivity (DTH) Candida albicans extract-based skin test antigen available to assess cell-mediated immunity.
CANDIN should not be used to diagnose or treat Type 1 allergy to Candida albicans.
Full Prescribing Information
SPHERUSOL® (Coccidioides immitis Spherule-Derived Skin Test Antigen)
The only FDA-approved skin test antigen to assess cell-mediated immunity to Coccidioides,
the causative agent of Valley Fever (coccidioidomycosis). Commonly referred to as the "Valley Fever Skin Test".
The use of SPHERUSOL to detect delayed-type hypersensitivity response in a general population with unknown exposure to Coccidioides has not been evaluated
Persons with acute or disseminated coccidioidomycosis may not develop a delayed-type hypersensitivity response to SPHERUSOL
Persons with immunodeficiency and a history of coccidioidomycosis may not develop a delayed-type hypersensitivity response to SPHERUSOL
The following third-party website was provided for your convenience, and Nielsen BioSciences, Inc. does not endorse, verify, or otherwise support the information contained in these websites. You are subject to the legal terms and conditions of use for third-party websites.